Showing results (191-200 of 601) with videos related to
Sort By:
Pageof 61
Nature Communications|September 6, 2018
Unravelling subclonal heterogeneity and aggressive disease states in TNBC through single-cell RNA-seqMihriban Karaayvaz, Simona Cristea, Shawn M Gillespie, et al.Cancer Discovery|October 1, 2017
mTOR and HDAC Inhibitors Converge on the TXNIP/Thioredoxin Pathway to Cause Catastrophic Oxidative Stress and Regression of RAS-Driven TumorsClare F Malone, Chloe Emerson, Rachel Ingraham, et al.Scientific Reports|November 9, 2022
Genomic analysis of early-stage lung cancer reveals a role for TP53 mutations in distant metastasisDebra Van Egeren, Khushi Kohli, Jeremy L Warner, et al.Cancer Research|August 18, 2018
In Vivo Estimation of Oncolytic Virus Populations within TumorsMi-Yeon Jung, Chetan P Offord, Matthew K Ennis, et al.Rare Tumors|December 9, 2010
Angiomatoid fibrous histiocytoma in a 25-year-old maleAaron Mansfield, Brenda Larson, Scott L Stafford, et al.Scientific Reports|July 27, 2016
ABCG2 regulates self-renewal and stem cell marker expression but not tumorigenicity or radiation resistance of glioma cellsBoyoung Wee, Alexander Pietras, Tatsuya Ozawa, et al.Cell Reports|March 15, 2023
Single-cell heterogeneity of EGFR and CDK4 co-amplification is linked to immune infiltration in glioblastomaKacper A Walentynowicz, Dalit Engelhardt, Simona Cristea, et al.Hematology Reports|November 25, 2024
Real-World Study of US Adults with Paroxysmal Nocturnal Hemoglobinuria Treated with PegcetacoplanBrian Mulherin, Apeksha Shenoy, Lily Arnett, et al.Biochemical and Biophysical Research Communications|November 4, 2004
Dynamic iodide trapping by tumor cells expressing the thyroidal sodium iodide symporterDavid Dingli, Elizabeth R Bergert, Zeljko Bajzer, et al.Cancer|March 29, 2006
Presence of unfavorable cytogenetic abnormalities is the strongest predictor of poor survival in secondary myelofibrosisDavid Dingli, Susan M Schwager, Ruben A Mesa, et al.Pageof 61